Most supportive evidence for the use of albumin in patients with ESLD is available for fluid replacement after large-volume paracentesis (>5 L ascites), for patients with hepatorenal syndrome (HRS), and for spontaneous bacterial peritonitis (SBP). The gene discussed is ALB; the disease is Ascites.